4
Changes in Ownership
Vanda Pharmaceuticals Inc. Filed Acc 0001209191-20-002027
SVP, Business Development sold 4,020 shares at $15.93 ($64,021)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Birznieks Gunther SVP, Business Development | 2020-01-02 | Sale | −4,020 | $15.93 | $64,021 | 147,231 | D: show line 1 in the form |
| Open-market sales · 4,020 sh · avg $15.93 · $64,021 | |||||||
Loading xslF345X03/doc4.xml…